Globe Newswire MONTREAL, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...\n more…
Zacks Investment Research Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that...\n more…
Zacks Investment Research Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks...\n more…
TipRanks Financial Blog Theratechnologies (THTX - Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Walsh from ...\n more…
Ticker Report Theratechnologies (NASDAQ:THTX - Get Free Report) announced its earnings results on Wednesday. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus...\n more…